Processa Pharmaceuticals Inc (PCSA) stock news · $5.9M cap
Processa Pharmaceuticals Inc (PCSA) is a biotechnology company listed on NASDAQ.
This PCSA news page leads with what Processa Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for PCSA yet. We will not pad this page with generic market recap.
Latest reported PCSA revenue for 2022-12-31 was $0. Net income was -$27.4M. PCSA currently screens at market cap $5.9M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the PCSA stock page; for the tape open the quote page.
PCSA stock news FAQ
What is PCSA's latest net income?
Latest cached Processa Pharmaceuticals Inc (PCSA) net income was -$27.4M. Statements: https://lician.com/financials/pcsa
What is PCSA's market cap?
Processa Pharmaceuticals Inc (PCSA) market cap is $5.9M on the latest cached fundamentals snapshot.
What kind of company is PCSA?
Processa Pharmaceuticals Inc (PCSA) is a biotechnology company listed on NASDAQ.
Where is PCSA stock news listed?
Cached stock news for Processa Pharmaceuticals Inc (PCSA) is listed at https://lician.com/news/pcsa. Filings: https://lician.com/sec/pcsa
Not investment advice.